Literature DB >> 31345604

Longitudinal study of upper extremity reachable workspace in fascioscapulohumeral muscular dystrophy.

Maya N Hatch1, Kiin Kim2, Gregorij Kurillo3, Alina Nicorici4, Craig M McDonald4, Jay J Han5.   

Abstract

Facioscapulohumeral Dystrophy (FSHD) results in slowly progressive strength impairment, especially the upper extremities. Recent discoveries regarding pathophysiology have led to exciting novel therapeutic strategies. To further facilitate drug development, improved FSHD outcome measures that are functionally-relevant and sensitive to longitudinal change will be critical. Recently, a motion sensor (Kinect)-based upper extremity outcome called 'reachable workspace' that provides a quantitative reconstruction of an individual's reachability was developed. In this study, changes in reachable workspace were tracked upwards for five-years in 18 FSHD subjects. Results show -1.63 %/year decline in total reachable workspace (p = 0.144); with most notable decline in the above-the-shoulder level quadrants (upper-lateral Q3: -9.5 %/year, p < 0.001 and upper-medial Q1: -6.8 %/ year, p = 0.063) with no significant changes in the lower quadrants (Q2, Q4). Reachable workspace declined more significantly if the subjects were challenged with 500 g wrist weights: total reachable workspace: -1.82 %/year, p = 0.039; Q1: -7.20 %/year, p = 0.041; Q3: -8.09 %/year, p = 0.001. Importantly, reachable workspace outcome was also able to distinguish subgroups in FSHD: mildly- and severely-affected with essentially unchanging reachability over years, and moderately-affected who demonstrate the most detectable changes longitudinally. The study demonstrates utility for measuring declines in upper quadrant reachability, and provides enrichment/stratification of FSHD populations most likely to show treatment effects in clinical trials. Published by Elsevier B.V.

Entities:  

Keywords:  Facioscapulohumeral muscular dystrophy; Kinect; Longitudinal; Reachable workspace; Upper extremity function

Year:  2019        PMID: 31345604      PMCID: PMC6996236          DOI: 10.1016/j.nmd.2019.05.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  20 in total

1.  A unifying genetic model for facioscapulohumeral muscular dystrophy.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Rinse Klooster; Sabrina Sacconi; Pilar Camaño; Johannes G Dauwerse; Lauren Snider; Kirsten R Straasheijm; Gert Jan van Ommen; George W Padberg; Daniel G Miller; Stephen J Tapscott; Rabi Tawil; Rune R Frants; Silvère M van der Maarel
Journal:  Science       Date:  2010-08-19       Impact factor: 47.728

2.  RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy.

Authors:  Lauren Snider; Amy Asawachaicharn; Ashlee E Tyler; Linda N Geng; Lisa M Petek; Lisa Maves; Daniel G Miller; Richard J L F Lemmers; Sara T Winokur; Rabi Tawil; Silvère M van der Maarel; Galina N Filippova; Stephen J Tapscott
Journal:  Hum Mol Genet       Date:  2009-04-09       Impact factor: 6.150

3.  Clinical trial preparedness in facioscapulohumeral dystrophy: outcome measures and patient access: 8-9 April 2013, Leiden, The Netherlands.

Authors:  R Tawil; D W Shaw; S M van der Maarel; S J Tapscott
Journal:  Neuromuscul Disord       Date:  2013-08-02       Impact factor: 4.296

4.  Reachable workspace reflects dynamometer-measured upper extremity strength in facioscapulohumeral muscular dystrophy.

Authors:  Jay J Han; Evan De Bie; Alina Nicorici; Richard T Abresch; Ruzena Bajcsy; Gregorij Kurillo
Journal:  Muscle Nerve       Date:  2015-06-19       Impact factor: 3.217

5.  A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.

Authors:  Costanza Lamperti; Greta Fabbri; Liliana Vercelli; Roberto D'Amico; Roberto Frusciante; Emanuela Bonifazi; Chiara Fiorillo; Carlo Borsato; Michelangelo Cao; Maura Servida; Francesca Greco; Rita Di Leo; Leda Volpi; Claudia Manzoli; Paola Cudia; Ebe Pastorello; Leopoldo Ricciardi; Gabriele Siciliano; Giuliana Galluzzi; Carmelo Rodolico; Lucio Santoro; Giuliano Tomelleri; Corrado Angelini; Enzo Ricci; Laura Palmucci; Maurizio Moggio; Rossella Tupler
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

6.  Clinical trial in Duchenne dystrophy. I. The design of the protocol.

Authors:  M H Brooke; R C Griggs; J R Mendell; G M Fenichel; J B Shumate; R J Pellegrino
Journal:  Muscle Nerve       Date:  1981 May-Jun       Impact factor: 3.217

7.  Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensor.

Authors:  Evan de Bie; Bjorn Oskarsson; Nanette C Joyce; Alina Nicorici; Gregorij Kurillo; Jay J Han
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-11-04       Impact factor: 4.092

8.  Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample.

Authors:  M L Mostacciuolo; E Pastorello; G Vazza; M Miorin; C Angelini; G Tomelleri; G Galluzzi; C P Trevisan
Journal:  Clin Genet       Date:  2009-03-23       Impact factor: 4.438

9.  Facioscapulohumeral muscular dystrophy functional composite outcome measure.

Authors:  Katy Eichinger; Chad Heatwole; Stanley Iyadurai; Wendy King; Lindsay Baker; Susanne Heininger; Amy Bartlett; Nuran Dilek; William B Martens; Michael Mcdermott; John T Kissel; Rabi Tawil; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2018-01-30       Impact factor: 3.217

Review 10.  Facioscapulohumeral muscular dystrophy.

Authors:  Rabi Tawil
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

View more
  2 in total

1.  Reachable workspace analysis is a potential measurement for impairment of the upper extremity in neuralgic amyotrophy.

Authors:  Jos IJspeert; Renee Lustenhouwer; Renske M Janssen; Jay J Han; Maya N Hatch; Ian Cameron; Rick C Helmich; Baziel van Engelen; Philip van der Wees; Alexander C H Geurts; Nens van Alfen; Jan T Groothuis
Journal:  Muscle Nerve       Date:  2022-06-21       Impact factor: 3.852

2.  Motion sensor-acquired reachable workspace correlates with patient-reported upper extremity activities of daily living (ADL) function in facioscapulohumeral dystrophy.

Authors:  Maya N Hatch; Gregorij Kurillo; Vicky Chan; Jay J Han
Journal:  Muscle Nerve       Date:  2020-12-01       Impact factor: 3.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.